Drugs Information:
Safinamide
Basic Information
|
|
||
| ID | DDInter1631 | |
| Drug Type | small molecule | |
| Molecular Formula | C17H19FN2O2 | |
| Molecular Weight | 302.349 | |
| CAS Number | 133865-89-1 | |
| Description | Safinamide is for the treatment of parkinson's disease. It was approved in Europe in February 2015, and in the United States on March 21, 2017. | |
| ATC Classification | N04BD03 | |
| IUPAC Name | (2S)-2-[({4-[(3-fluorophenyl)methoxy]phenyl}methyl)amino]propanamide | |
| InChI | NEMGRZFTLSKBAP-LBPRGKRZSA-N | |
| Canonical SMILES | C[C@H](NCC1=CC=C(OCC2=CC(F)=CC=C2)C=C1)C(N)=O | |
| Useful Links | DrugBank ChEBI PubChem Substance ChemSpider BindingDB Wikipedia ChEMBL ZINC | |
Interactions with
Safinamide
Filter:
| Severity level | ID | Name | Mechanism | Detail |
|---|
Interactions with diseases
Filter:
| Severity level | Disease name | Text | References |
|---|
Interactions with foods
Filter:
| Severity level | Food name | Description | Management | Mechanism | References |
|---|
Interactions with compound preparation
| Multi-DRUG trade | Multi-DRUG | Drug type | Warning | Note |
|---|